These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7636387

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies.
    Toren A, Barak V, Novick D, Nagler A.
    Cytokines Cell Mol Ther; 1997 Sep; 3(3):153-8. PubMed ID: 9426973
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation.
    Yabe M, Yabe H, Hattori K, Hinohara T, Morimoto T, Kato S, Kusunoki A.
    Bone Marrow Transplant; 1994 Nov; 14(5):741-6. PubMed ID: 7889006
    [Abstract] [Full Text] [Related]

  • 6. Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease.
    Tanaka J, Imamura M, Kasai M, Zhu X, Kobayashi S, Imai K, Hashino S, Higa T, Sakurada K, Miyazaki T.
    Bone Marrow Transplant; 1994 Nov; 14(5):695-701. PubMed ID: 7889002
    [Abstract] [Full Text] [Related]

  • 7. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease.
    Liem LM, Koelman CA, Doxiadis II, van Houwelingen JC, Goulmy E, Claas FH.
    Bone Marrow Transplant; 1997 Aug; 20(3):227-34. PubMed ID: 9257891
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A possible association between the presence of interleukin-4-secreting cells and a reduction in the risk of acute graft-versus-host disease.
    Takabayashi M, Kanamori H, Takasaki H, Yamaji S, Koharazawa H, Taguchi J, Tomita N, Fujimaki K, Fujisawa S, Maruta A, Ishigatsubo Y.
    Exp Hematol; 2005 Feb; 33(2):251-7. PubMed ID: 15676220
    [Abstract] [Full Text] [Related]

  • 13. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M, Iravani M, Babaee GR, Ghavamzadeh A.
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [Abstract] [Full Text] [Related]

  • 14. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F.
    J Clin Oncol; 2004 Feb 01; 22(3):416-23. PubMed ID: 14691124
    [Abstract] [Full Text] [Related]

  • 15. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
    Romano V, Castagnola E, Dallorso S, Lanino E, Calvi A, Silvestro S, Morreale G, Giacchino R, Dini G.
    Bone Marrow Transplant; 1999 Feb 01; 23(3):271-5. PubMed ID: 10084259
    [Abstract] [Full Text] [Related]

  • 16. Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice.
    Brok HP, Heidt PJ, van der Meide PH, Zurcher C, Vossen JM.
    J Immunol; 1993 Dec 01; 151(11):6451-9. PubMed ID: 8245478
    [Abstract] [Full Text] [Related]

  • 17. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F, Labopin M, Gluckman E, Prentice HG, Vernant JP, Zwaan F, Granena A, Gahrton G, De Witte T, Gratwohl A, Reiffers J, Gorin NC.
    Bone Marrow Transplant; 1996 Jan 01; 17(1):13-8. PubMed ID: 8673048
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E, Balduzzi A, Zappa G, Lucchini G, Perseghin P, Andrè V, Todisco E, Rahal D, Migliavacca M, Longoni D, Solinas G, Villa A, Berti E, Mina PD, Parma M, Allavena P, Biagi E, Rovelli A, Biondi A, D'Amico G.
    Transplantation; 2009 Dec 15; 88(11):1261-72. PubMed ID: 19996925
    [Abstract] [Full Text] [Related]

  • 19. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Körholz D, Kunst D, Hempel L, Söhngen D, Heyll A, Bönig H, Göbel U, Zintl F, Burdach S.
    Bone Marrow Transplant; 1997 Apr 15; 19(7):691-5. PubMed ID: 9156246
    [Abstract] [Full Text] [Related]

  • 20. Markedly increased serum erythropoietin levels following conditioning for allogeneic bone marrow transplantation.
    Abedi MR, Bäckman L, Boström L, Lindbäck B, Ringdén O.
    Bone Marrow Transplant; 1990 Aug 15; 6(2):121-6. PubMed ID: 2207449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.